Is methenamine (methenamine) safe to use in patients with gout?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Methenamine and Gout Safety

Methenamine hippurate is safe to use in patients with gout, as there is no evidence of interaction between methenamine and gout pathophysiology or its treatments.

No Contraindication Exists

  • Methenamine hippurate is not listed as a contraindication or medication requiring caution in patients with gout according to major gout management guidelines 1.
  • The American College of Rheumatology 2020 guidelines comprehensively address medications that contribute to gout risk (diuretics, calcineurin inhibitors, low-dose aspirin, niacin) but do not mention methenamine as problematic 2.
  • Methenamine does not affect serum uric acid levels or interfere with urate metabolism 3, 4.

Mechanism of Action Supports Safety

  • Methenamine works by converting to formaldehyde in acidic urine to prevent urinary tract infections, a mechanism completely independent of purine metabolism or uric acid handling 4.
  • The drug does not interact with standard gout treatments including NSAIDs, colchicine, corticosteroids, or urate-lowering therapies like allopurinol 1, 3.

Clinical Evidence

  • Long-term studies of methenamine hippurate (up to 16 months) showed no adverse effects on renal function or development of urinary calculi, which are relevant concerns in gout patients 3.
  • The medication has a low adverse event profile overall, with gastrointestinal effects being the most common, not metabolic or rheumatologic complications 4, 5.
  • Studies in elderly patients with chronic conditions demonstrated safety over 6-month treatment periods without metabolic complications 5, 6.

Practical Considerations

  • Patients with gout who require urinary tract infection prophylaxis can safely receive methenamine hippurate at standard dosing (1 g twice daily) 3, 5.
  • Continue all gout medications (colchicine, NSAIDs, allopurinol, febuxostat) without dose adjustment when adding methenamine 1.
  • Monitor renal function as you would for any gout patient, particularly those on urate-lowering therapy, but methenamine itself does not worsen renal function 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medications That Contribute to Gout

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Methenamine hippurate for preventing urinary tract infections.

The Cochrane database of systematic reviews, 2012

Research

Treatment with methenamine hippurate in the patient with a catheter.

The Journal of international medical research, 1976

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.